# Allinaire Therapeutics Inc. — Form D

Allinaire Therapeutics Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-14. The offering totals $700K, of which $700K was reported sold. Industry: Other.

## Offering

- Filed: 2026-04-14
- Form: D
- Accession: 0002113399-26-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $700K
- Amount sold: $700K
- Investors: 2
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-580441

## Issuer

- Name: Allinaire Therapeutics Inc.
- CIK: 0002113399
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 11000 CEDAR AVE #18, CLEVELAND, OH, 44106
- Phone: 484.367.7303

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Arthur Bertelson | Related Person | Cleveland, OH |
| Samantha Ginther | Related Person | Cleveland, OH |
| Douglas W.P. Hay | Related Person | Cleveland, OH |
| Satish Jindal | Related Person | Cleveland, OH |

## More

- [CIK 2113399 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2113399&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002113399-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.